U.S. Markets open in 3 hrs 6 mins

Is Invacare Corporation (NYSE:IVC) Worth $17.45 Based On Its Intrinsic Value?

Felix Olson

Does the share price for Invacare Corporation (NYSE:IVC) reflect it’s really worth? Today, I will calculate the stock’s intrinsic value using the discounted cash flow (DCF) method. Anyone interested in learning a bit more about intrinsic value should have a read of the Simply Wall St analysis model. If you are reading this after February 2018 then I highly recommend you check out the latest calculation for Invacare here.

Is IVC fairly valued?

I use what is known as the 2-stage model, which simply means we have two different periods of varying growth rates for the company’s cash flows. Generally the initial phase has higher growth rates that plateau over time. To begin, I use the analyst consensus forecast of IVC’s levered free cash flow (FCF) over the next five years and discounted these values at the cost of equity of 9.25%. When estimates weren’t available, I’ve extrapolated the average annual growth rate over the previous five years, capped at a reasonable level. This resulted in a present value of 5-year cash flow of $75.4M. Want to understand how I calculated this value? Check out our detailed analysis here.

NYSE:IVC Future Profit Feb 7th 18

The graph above shows how IVC’s top and bottom lines are expected to move going forward, which should give you some color on IVC’s outlook. Now we need to calculate the terminal value, which is the business’s cash flow after the first stage. It’s appropriate to use the 10-year government bond rate of 2.8% as the stable growth rate, which is rightly below GDP growth, but more towards the conservative side. Discounting the terminal value back five years gives us a present value of $324.9M.

The total value is the sum of cash flows for the next five years and the discounted terminal value, which results in the Total Equity Value, which in this case is $400.3M. The last step is to then divide the equity value by the number of shares outstanding. This results in an intrinsic value of $12.19, which, compared to the current share price of $17.45, we find that Invacare is quite expensive at the time of writing.

Next Steps:

Although the valuation of a company is important, it shouldn’t be the only metric you look at when researching a company. What is the reason for the share price to differ from the intrinsic value? For IVC, there are three essential aspects you should look at:

PS. Simply Wall St does a DCF calculation for every US stock every 6 hours, so if you want to find the intrinsic value of any other stock just search here.


To help readers see pass the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned.